基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
No content for now
Research Interests
Papers共 30 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Poojith Nuthalapati,Mohan Krishna Ghanta,Batoul Farran,Santenna Chenchula, Venkata Aksheena Varahi Vedam, Vigneshwaran Pukalendiran,Krishna Chaitanya Amerneni,L. V. K. S. Bhaskar
Smart Nanomaterials for Infectious Diseasespp.272-308, (2024)
Santenna Chenchula,Madhu Bhargavi Chandra,Madhu Babu Adusumilli,Sai Nikhila Ghanta, Anusha Bommasani,Anitha Kuttiappan,R. Padmavathi,Krishna Chaitanya Amerneni,Radhika Chikatipalli,Mohan Krishna Ghanta, Samarra Simha Reddy,K. Mythili Bai,
REVIEWS IN MEDICAL VIROLOGYno. 1 (2024): e2515-e2515
Santenna Chenchula, Phulen Sharma,Mohan Krishna Ghanta,Krishna Chaitanya Amerneni, Padmavathi Rajakarunakaran, Pavani Saggurthi,Madhu Bhargavi Chandra,Rupesh Gupta,Madhavrao Chavan
Current diabetes reviews (2024)
medRxiv (Cold Spring Harbor Laboratory) (2023)
SANTENNA CHENCHULA, PHULEN Sharma,Mohan Krishna Ghanta,Krishna Chaitanya Amerneni,Sushil Sharma,Madhavrao Chavan,Padmavathi R,Rupesh Gupta, Pavani Saggurthi
Research Square (Research Square) (2023)
Santenna Chenchula,Mohan Krishna Ghanta,Krishna Chaitanya Amerneni, Padmavathi Rajakarunakaran,Madhu Bhargavi Chandra,Madhavrao Chavan,Rupesh Gupta
medRxiv (Cold Spring Harbor Laboratory) (2023)
Venkata Aksheena Varahi Vedam,Mohan Krishna Ghanta,Suvarna Jyothi Kantipudi,Darling Chellathai David, Melanathuru Vijayalakshmi,Poojith Nuthalapati
Journal of Pharmacology and Pharmacotherapeuticsno. 3 (2022): 284-292
Load More
Author Statistics
#Papers: 30
#Citation: 68
H-Index: 5
G-Index: 7
Sociability: 5
Diversity: 0
Activity: 1
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn